Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus
Authors:
- Eric CaumesECEric Caumes
- Olivier ChosidowOCOlivier Chosidow
- Jean RevuzJRJean Revuz
- Jean-Claude RoujeauJRJean-Claude Roujeau
- 1 April 1992
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 26 (4) , 567-574
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Co-trimoxazole for toxic epidermal necrolysis in AIDSThe Lancet, 1991
- Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosisThe Lancet, 1991
- Toxic epidermal necrolysis (Lyell syndrome)Journal of the American Academy of Dermatology, 1990
- Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985Archives of Dermatology, 1990
- The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatientsArchives of Dermatology, 1990
- Current Recommendations and Future Prospects in the Treatment of ToxoplasmosisDrugs, 1989
- Cutaneous manifestations of human immunodeficiency virus in Lusaka, ZambiaJournal of the American Academy of Dermatology, 1988
- Treatment of Infections Associated with Human Immunodeficiency VirusNew England Journal of Medicine, 1988
- Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patientsArchives of Dermatology, 1987
- ADVERSE REACTIONS ASSOCIATED WITH PYRIMETHAMINE-SULFADOXINE PROPHYLAXIS FOR PNEUMOCYSTIS CARINII INFECTIONS IN AIDSThe Lancet, 1985